Dorte Vistisen
Dorte Vistisen
Steno Diabetes Center Copenhagen
Verified email at - Homepage
Cited by
Cited by
Global healthcare expenditure on diabetes for 2010 and 2030
P Zhang, X Zhang, J Brown, D Vistisen, R Sicree, J Shaw, G Nichols
Diabetes research and clinical practice 87 (3), 293-301, 2010
GLP-1 response to oral glucose is reduced in prediabetes, screen-detected type 2 diabetes, and obesity and influenced by sex: the ADDITION-PRO study
K Færch, SS Torekov, D Vistisen, NB Johansen, DR Witte, A Jonsson, ...
Diabetes 64 (7), 2513-2525, 2015
Moving to an A1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups
DL Christensen, DR Witte, L Kaduka, ME Jørgensen, K Borch-Johnsen, ...
Diabetes care 33 (3), 580-582, 2010
Risk scores for type 2 diabetes can be applied in some populations but not all
C GLumer, D Vistisen, K Borch-Johnsen, S Colagiuri, ...
Diabetes care 29 (2), 410-414, 2006
There really is an epidemic of type 2 diabetes
S Colagiuri, K Borch-Johnsen, C Glümer, D Vistisen
Diabetologia 48, 1459-1463, 2005
Insulin resistance is accompanied by increased fasting glucagon and delayed glucagon suppression in individuals with normal and impaired glucose regulation
K Færch, D Vistisen, G Pacini, SS Torekov, NB Johansen, DR Witte, ...
Diabetes 65 (11), 3473-3481, 2016
Risk of cardiovascular disease and death in individuals with prediabetes defined by different criteria: the Whitehall II study
D Vistisen, DR Witte, EJ Brunner, M Kivimäki, A Tabák, ME Jørgensen, ...
Diabetes Care 41 (4), 899-906, 2018
Prediction of first cardiovascular disease event in type 1 diabetes mellitus: the Steno Type 1 Risk Engine
D Vistisen, GS Andersen, CS Hansen, A Hulman, JE Henriksen, ...
Circulation 133 (11), 1058-1066, 2016
Determinants of aortic stiffness: 16-year follow-up of the Whitehall II study
NB Johansen, D Vistisen, EJ Brunner, AG Tabák, MJ Shipley, ...
PloS one 7 (5), e37165, 2012
Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall II cohort study
K Færch, DR Witte, AG Tabák, L Perreault, C Herder, EJ Brunner, ...
The lancet Diabetes & endocrinology 1 (1), 43-51, 2013
Patterns of obesity development before the diagnosis of type 2 diabetes: the Whitehall II cohort study
D Vistisen, DR Witte, AG Tabak, C Herder, EJ Brunner, M Kivimäki, ...
PLoS medicine 11 (2), e1001602, 2014
The Evaluation of Screening and Early Detection Strategies for Type 2 Diabetes and Impaired Glucose Tolerance (DETECT-2) update of the Finnish diabetes risk score for …
M Alssema, D Vistisen, MW Heymans, G Nijpels, C Glümer, PZ Zimmet, ...
Diabetologia 54, 1004-1012, 2011
Progressive decline in estimated glomerular filtration rate in patients with diabetes after moderate loss in kidney function—even without albuminuria
D Vistisen, GS Andersen, A Hulman, F Persson, P Rossing, ...
Diabetes Care 42 (10), 1886-1894, 2019
Sleep duration and sleep quality are associated differently with alterations of glucose homeostasis
S Byberg, ALS Hansen, DL Christensen, D Vistisen, M Aadahl, ...
Diabetic Medicine 29 (9), e354-e360, 2012
Metabolically healthy obesity and ischemic heart disease: a 10-year follow-up of the Inter99 study
L Hansen, MK Netterstrøm, NB Johansen, PF Rønn, D Vistisen, ...
The Journal of Clinical Endocrinology & Metabolism 102 (6), 1934-1942, 2017
Evidence of a liver–alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids
NJ Wewer Albrechtsen, K Færch, TM Jensen, DR Witte, J Pedersen, ...
Diabetologia 61, 671-680, 2018
Trajectories of glycaemia, insulin sensitivity and insulin secretion in South Asian and white individuals before diagnosis of type 2 diabetes: a longitudinal analysis from the …
A Hulman, RK Simmons, EJ Brunner, DR Witte, K Færch, D Vistisen, ...
Diabetologia 60, 1252-1260, 2017
Comparisons of metabolic syndrome definitions in four populations of the Asia-Pacific region
CMY Lee, RR Huxley, M Woodward, P Zimmet, J Shaw, NH Cho, HR Kim, ...
Metabolic syndrome and related disorders 6 (1), 37-46, 2008
Progression to impaired glucose regulation and diabetes in the population-based Inter99 study
S Engberg, D Vistisen, C Lau, C Glümer, T Jørgensen, O Pedersen, ...
Diabetes care 32 (4), 606-611, 2009
Pathophysiological characteristics underlying different glucose response curves: a latent class trajectory analysis from the prospective EGIR-RISC study
A Hulman, DR Witte, D Vistisen, B Balkau, JM Dekker, C Herder, ...
Diabetes Care 41 (8), 1740-1748, 2018
The system can't perform the operation now. Try again later.
Articles 1–20